Search Results

Search Results for""
AMBER (Advanced Materials and BioEngineering Research) is a Science Foundation Ireland funded centre that provides a partnership between leading researchers in materials science and industry. Materials science has been described as the science of stuff! We are researching materials that will transform everyday products of the future, from mobile phones to knee implants, batteries to beer bottles. AMBER links industry to research programmes and the aim of the centre is to develop products that directly impact everyone’s quality of life such as the development of the next generation computer chips and new medical implants and pharmaceuticals that will improve patient care.AMBER is jointly hosted in Trinity College Dublin by CRANN and the Trinity Centre for Bioengineering, in collaboration with University College Cork and the Royal College of Surgeons in Ireland. AMBER brings together Ireland’s leading material science researchers working across the disciplines of Physics, Chemistry, Bioengineering and Medicine; with an international network of collaborators and companies.
Read More
New Harvest
Established in 2004, New Harvest is the non-profit research institute building and establishing the field of cellular agriculture. We strategically fund and conduct open, public, collaborative research that reinvents the way we make animal products - without animals.
Read More
The Company: Advanced BioMatrix is a leader in the life science of three dimensional (3D) applications for tissue culture, cell assay, and cell proliferation. Our products are recognized as the standard for purity, functionality, and consistency. We have extensive expertise in production, isolation, purification, lyophilization, cell culture and testing of proteins, adhesion peptides, attachment factors, substrate rigidity, and other 3D matrix products. Our expertise and knowledge is being employed to assure that our products are of the highest quality, are consistent from lot-to-lot and are easy-to-use for our research customers. Vision: Transforming science to a new level of discovery by providing advanced technologies through innovative 3D matrix products. Facilities: Advanced BioMatrix is located in the San Diego, California region which has the largest biotech cluster. Its state-of-the-art facility located in Carlsbad, California includes manufacturing clean rooms, quality control laboratories, and R&D suites to ensure and support product quality and development of new innovative products. Why 3D Matters: 3D gels allow for the study of the effects of the mechanical properties of the ECM, such as density and rigidity, on cell development, migration, and morphology. Unlike 2D systems, 3D environments allow cell extensions to simultaneously interact with integrins on all cell surfaces, resulting in the activation of specific signaling pathways. Gel stiffness or rigidity also affects cell migration differently in 3D versus 2D environments. Furthermore, integrin-independent mechanical interactions resulting from the entanglement of matrix fibrils with cell extensions are possible in 3D systems, but not in 2D systems where the cells are attached to a flat surface.
Read More
Based in San Diego, CA, Organovo is the only public company that operates in the field of human tissue 3D printing. Its bioprinter has already achieved some breakthrough results in the printing of live liver tissue that responds to drug stimuli. Bioprinting organs such as liver, kidney and skin for transplants is one of the great promises of additive manufacturing methods and it is usually explored most at a academic level, without real commercial applications in sight for at least the next 5 years. However Organovo's technology is viewed as viable by the scientific community and holds great potential.
Read More
Advanced Solutions, Inc. and its subsidiaries operate as a diversified technology company providing integrated software solutions and services allowing businesses to achieve more effective products, processes, technologies and ideas. The Company serves clients in the architecture, engineering, construction, manufacturing, material handling, retail and biomedical industries. Advanced Solutions leverages technology to improve business processes, product quality and customer satisfaction.
Read More
RegenHU is an innovative biomedical company located in Switzerland, belonging to the CPA Group SA. RegenHU acts as a biosystem architect exploiting new biomanufacturing solutions in order to respond to the emerging challenges facing the biomedical industry. The company benefits from exclusive patented technologies resulting from many years of research within international universities and partners.
Read More
Swedish start up which manufacturers the CELLINK bioink, compatbile with most extrusion based 3D bioprinters on the market.CELLINK is the final puzzle piece in the 3D Bioprinting industry we all have been waiting for. CELLINK is a bioink that can universally be used on a wide range of 3D Bioprinters. CELLINK can also be used independently of any printing device, in case you want to perform simpler experiments of 3D cell culturing. The unique biocompatibility and printability of our bioink offers outstanding results that will take your research to the next level!The company also launched the INKREDIBLE 3D bioprinter, starting at $5,000
Read More
Skolokovo Research Center resident company producing Russia's first bioprinter
Read More
There are those who wish the world was different, and those who work to change it every day. At Modern Meadow we are working tirelessly to see this new future materialize; one where man (or woman) makes the material and the animals roam free.Our team unites smart, passionate, and caring people who innovate new leather materials to excite customers and do better for the planet. Biology and materials science are our foundation, engineering and analytics our strength, and design our core. We're unlocking the capabilities of nature to solve our biggest sustainability challenges.
Read More

A new dimension to biomedical engineering

regenHU is an innovative biomedical company located in Switzerland, belonging to the CPA Group SAregenHU acts as a biosystem architect exploiting new biomanufacturing solutions in order to respond to the emerging challenges facing the biomedical industry. regenHU benefits from exclusive patented technologies resulting from many years of research within international universities and partners.

Value Proposition

Advancements in medical Science, biology, cell-based therapies, as well as the ever increasing market entry barriers induced by biomedical product regulations and legislations, ask for innovative solutions to create biogical relevant tissue models. It is well known nowadays that these requirements can only be fulfilled if science is able to mimic natural morphologic environments of the third dimension.We provide the tools to enter the third dimension
Read More
Biomedical research is gravitating towards 3D cell culture models and tissue printing. At n3D, we sell kits and services for 3D cell culture. Our core technology is the magnetization of cells, which can then be directed using magnetic forces. In this manner, we can either levitate or bioprint cells. These cultures are faster to assemble than other systems and easier to handle with magnets without losing samples. Check out our products and our services for more information on our technology, and how we can help you!There is a growing push for biomedical and pharmaceutical research to transition towards three-dimensional (3D) cell culture models. Model selection is basically a choice between representation (animal testing) and throughput (in vitro cell culture). 3D cell culture brings the best of both worlds, but technical limitations in cost and handling have prevented its widespread use.To overcome these challenges, Nano3D Biosciences (n3D) has developed magnetic cell culture, where we magnetize cells using NanoShuttleTM-PL, and then rapidly print them into microtissues using magnetic force. This is an easy method for 3D cell culture that works with any cell type, making it ideal for biomedical research and high-throughput compound screening.We offer a wide product line for our technology with kits that are easy to use and fit seamlessly into existing cell culture workflows. We also provide services, in cell culture optimization or contract research, where we leverage our expertise in 3D cell culture to deliver quality results.At n3D, our goal is to develop our magnetic cell culture technology into the industry standard for 3D cell culture, with longer term focuses on personalized medicine and regenerative medicine.
Read More

An Emerging Tool for Science & Technology

3D printing has recently become popular because of its ease and speed to customise 3D designs and turn them into real physical objects. 3D scientific and biological printing takes it further by 3D printing living cells, tissues and other biomaterials such as bacteria, antibodies, antigens, bio-gels, medicine, food materials and bio-polymers.

Scientists and engineers around the world continue to explore and study how the arrangement and design of living cells and other bio- and non-bio materials using 2D and/or 3D bio-printing can bring great potentials and applications in fields such as research & development, diagnostics, personalised medicine and drug development and testing.


We are a group of enthusiastic scientists, engineers and entrepreneurs coming together to bring new and disruptive technologies and sciences to the world. Bio3D Technologies is the fruit of our research and efforts, and we are proud to be one of the world's bioprinting pioneers.Together, we have created world's first and Singapore's first true scientific and biological 3D printer with multiple print heads, modular design, nozzle-to-platform auto-alignment, remote viewing and control etc. We are also the first to integrate an anti-vibration levitating platform into a 3D printer.We hope to bring affordable and reliable bioprinting and microprinting technologies to every researcher and engineer for the advancement of science and technology.With the introduction of Bio3D Explorer, we made 3D bioprinting even more affordable and accessible. Once again, we created another world's first- a foldable bioprinter that can be transported around easily.
Read More
3Dynamic Systems is a Swansea University UK-based 3D-Bioprinting manufacturer offering the first commercial and affordable 3D-Bioprinting systems. Our 3D-Bioprinters stem from our teams success in engineering tissues using Bioprinting technology. Our aim is to bring affordable and reliable bioprinting technologies to scientists and engineers who carry out research in the field of tissue engineering. Researchers from across the world wanted a flexible 3D-Bioprinter that was easy to install, operate and which offers value for money. This is what we have produced, accessible 3D bioprinting technology. Now you can procure this technology. Every machine is made to order using the same high quality materials and precise control systems, which is based on years of research and development. Every system is made to the same high tolerances that we have aspired to since day one. With a durable steel superstructure our machines are built to last. Our Alpha and Omega 3D-Bioprinters are dynamic, adaptive and durable technologies which are easy to use, repeatable and precisely deposit biological materials in 3D. The ability to engineer 3D tissue systems gives researchers in the field a tool to perform repeatable research into the sphere of 3D-Bioprinting. Be it if you are working with stem cell systems, cancer research, antibodies, proteins and/or bacteria research. Our systems can aid you in depositing materials accurately and efficiency in 3D.
Read More
Aspect Biosystems is a Canadian biotechnology company founded in November, 2013. The company spun out from two internationally recognized research groups in engineering and medicine at the University of British Columbia. Aspect Biosystems is working towards a future where doctors determine which drugs work for their patients before prescribing them, where animals are no longer needed for the development of new therapeutics, and where lifesaving transplant organs are created, not harvested. To realise these goals, Aspect has developed a disruptive 3D bioprinting platform technology capable of creating living human tissues on demand.Our initial products aim to improve the predictive accuracy of the pre-clinical drug discovery process by providing the industry and researchers with the technology to create highly customized physiologically-relevant 3D human tissue models that they can employ in the development of new drugs. Aspect’s technology has the potential to drive a fundamental shift in the pharmaceutical industry, enabling the development of completely new therapeutics, and enabling pharma to test drugs they may have shelved in the past due to a lack of appropriate models. Furthermore, Aspect’s technology has the potential to significantly reduce the use of laboratory animals, supporting an industry wide mandate to reduce, refine and replace animal testing. Aspect has a long-term vision to expand beyond applications in drug development, by enabling Human Tissues on Demand™ for broad applications in the life sciences including regenerative medicine and organ transplantation.
Read More
Rainbow Biosciences, LLC, a new division of Rainbow Coral Corp. (RBCC), is a new company focused on identifying, developing and marketing the next generation of bioscience solutions for physicians, researchers and pharmaceutical engineers. The company is positioned to leverage proven resources that assess, enhance and realize the commercial potential of bioscience discoveries. We are forging connections between and among local academia and industry experts to promote commercially viable research. Our new technology products are poised to deliver substantial returns to early investors.


RBCC President and CEO Kimberly Palmer is a healthcare expert in charge of implementing RBCC’s developing business strategy in the field of regenerative medicine. For the past eight years, Ms. Palmer has served as a business consultant to private surgeons, providing administrative and clinical support for a variety of medical practices. As a registered nurse, she also brings extensive experience with surgical pre- and post-operative patient care to RBCC.At RBCC, Ms. Palmer is spearheading the marketing and development of new breakthroughs in the multi-billion dollar global regenerative and precision medicine markets.
Read More
In 2004, InnoTERE was founded by Dr. Berthold Nies and took up its business in Dresden in 2005. As a result of our growth we moved to Pharmapark Radebeul at 1st January 2012. Since 2014 Erich Roethlisberger is our second Managing Director in the areas of marketing and sales.Long-standing experiences in industrial research and development of biomaterials as well as the location in Dresden with its competences in materials science and biomaterials are solid basements for successful development of innovative products for bone tissue regeneration.As an innovative company, we have set ourselves the target to explore, develop and produce in close collaboration with researchers and clinicians new products for the treatment of bone damage and finally market as medical devices. One of our development priorities form novel bone cements on the basis of calcium phosphates and polymers. These bone cements enable a minimally invasive treatment of bone defects. We join together team members and cooperation partners who share our vision of innovative biomaterials for the well-being of affected patients. We further the creativity and skills of our team members and encourage their willingness to cooperate with interdisciplinary partners.InnoTERE is a founding member of the innovation incentive "Molecular Designed Biological Coating" (MBC) promoted by the Federal Ministry of Education and Research (BMBF) lasting from 2007 to 2010, which was awarded "Selected Landmark 2008 in the Land of Ideas"In 2008 InnoTERE was successfully certificated EN ISO 9001:2008 and EN ISO 13485:2012 in the scope of design/development, manufacturing and distribution of bone implants, bone cements and bone substitute materials.
Read More
RoosterBio is a products and technology company focused on accelerating the development of a sustainable regenerative medicine industry, one customer at a time.RoosterBio’s products are high volume, affordable, and well-characterized adult mesenchymal stem cells (MSCs) with highly engineered media systems.  RoosterBio has simplified and standardized how stem cells are purchased, expanded, and used in development, leading to time and costs savings for customers.  Our innovative products are ushering in a new era of productivity and standardization into the field (as seen by customer product reviews), and researchers spend new found time & money performing more high-value experiments, accelerating the road to discovery in Regenerative Medicine.RoosterBio's dedicated team has relevant technical, operational and regulatory experience and are considered leaders in the fields of Bio-manufacturing and Regenerative Medicine.  The team has over 20 years of experience with the major cell and media supply companies including BD, Thermo Fisher (Life Technologies) and Lonza. The team are experts in cell and tissue technology, and have an intimate understanding of the cell supply needs of the industry.RoosterBio leads the field of new-thinkers in stem cell research, cell and tissue engineering, and the commercialization of regenerative and biofabrication technologies.   RoosterBio can be followed on our highly regarded blog Democratizing Cell Technologies.
Read More
Mission MERLN aims to maintain a leading position in the field of biomedical engineering by combining creative research with training of a generation of interdisciplinary scientists. MERLN’s activities operate at the interface of biology and engineering and we aim to maximize outreach at the level of public involvement, development and commercialization of research. MERLN’s vision is based on sharing of knowledge, infrastructure and ambition.Research Research at MERLN is focused on developing novel and breakthough technologies to advance the field of repair and regeneration of both tissues and functional organs. The strategy includes, amongst others, the development of “smart” biomaterials which can trigger intrinsic tissue repair mechanisms mediated by the patient’s own cells.Education MERLN’s scientists will be involved in educational activities within different undergraduate and graduate programmes. Our expertise lies in biology, chemistry, materials science and engineering, with a distinct emphasis on biomedical applications, including regenerative medicine.Collaboration Scientists at MERLN have an extensive network of collaborators within research institutions in and outside the Netherlands as well as with a number of biomedical companies, including their own spin-off companies. Newly situated in a hospital setting, close collaboration with medical experts will expedite the testing and use of our technoligies in a clinically relevant setting.
Read More
The recently announced Regenovo is the latest in a line of medical grade 3D bioprinters that is still under development and showing promising results. Coming out of the Hanghou University of Science and Technology in the eastern Zhejiang Province of China, the Regonovo has already produced numerous gelatinous, semi-transparent 3D printed ears, kidneys and various other conglomerations of cells in sterile environments. The printer uses medical polymers, live cells, inorganic and hydrogel materials to create a scaffold from which cells are cultured to create living tissue.
Read More

The Business of 3D Printing is Evolving

Don't miss out on opportunities: enter your email to receive news,
updates and exclusive offers directly to your inbox

This information will never be shared with third parties